BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3509453)

  • 21. [Aztreonam in severe gram-negative infections in hospitalized patients. Clinical experience in Spain. Preliminary data].
    García-Rodríguez JA; Rabinad E
    Med Clin (Barc); 1987 Apr; 88(13):538-43. PubMed ID: 3586736
    [No Abstract]   [Full Text] [Related]  

  • 22. [Efficiency and possibility of the use of aztreonam in bacterial infections caused by gram-negative organisms].
    Caramia G; Compagnoni L; Pettinari A; Gregorini S
    Minerva Pediatr; 1986 Sep; 38(17-18):773-7. PubMed ID: 3796535
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative study of the effectiveness and renal tolerance of aztreonam (1 daily dosage) and gentamycin (2 daily doses) in the therapy of renal and urinary infections].
    Bonadio M; Maccanti O; Pulitanò L; Galigani P; Palla R
    G Ital Chemioter; 1985; 32(2):459-63. PubMed ID: 3914435
    [No Abstract]   [Full Text] [Related]  

  • 24. [Aztreonam in the treatment of infections of the urinary tract in childhood].
    Ravelli A; Fornari M; Visconti L; De Luca B; Nespoli L; Martini A
    G Ital Chemioter; 1985; 32(2):427-30. PubMed ID: 3833583
    [No Abstract]   [Full Text] [Related]  

  • 25. [Aztreonam in the treatment of bacterial infections in subjects with malignant blood diseases].
    Invernizzi R; Nastasi G; Mazzone A; Perseghin P; Michienzi M; Rizzo SC
    G Ital Chemioter; 1985; 32(2):453-7. PubMed ID: 3833587
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical evaluation of aztreonam in the treatment of urinary infections in pediatrics].
    Impellizzeri A; Nicolosi VM; Raimondi A; Sortino C; Leocata A
    G Ital Chemioter; 1985; 32(2):431-2. PubMed ID: 3833584
    [No Abstract]   [Full Text] [Related]  

  • 27. [Aztreonam in infections caused by gram-negative aerobic bacilli].
    Rodríguez French A; Kenion G; Rodríguez C
    Rev Med Panama; 1988 Jan; 13(1):4-8. PubMed ID: 3347772
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic effects and tolerance of aztreonam in infections of the urinary tract in childhood].
    Zappulla F; Mazzanti L; Sandri S; Varoli O; Bernardi F; Villa MP
    G Ital Chemioter; 1985; 32(2):433-6. PubMed ID: 3833585
    [No Abstract]   [Full Text] [Related]  

  • 29. Aztreonam in the treatment of urinary tract infections: a multicenter trial.
    Martelli A; Cortecchia V; Ventriglia L
    Chemotherapy; 1989; 35 Suppl 1():8-14. PubMed ID: 2659294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with aztreonam in Europe: a summary of studies in Belgium, England, Finland, Ireland, the Netherlands, Norway, Portugal, and Sweden.
    Norrby SR
    Rev Infect Dis; 1985; 7 Suppl 4():S836-9. PubMed ID: 2934788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effective use of gentamicin in life-threatening sepsis.
    Noone P; Pattison JR; Davies DG
    Postgrad Med J; 1974 Nov; 50 Suppl 7():9-16. PubMed ID: 4549326
    [No Abstract]   [Full Text] [Related]  

  • 32. Aztreonam: early clinical studies in New Jersey.
    Johnson ES; Eng RK; Perez EM; Smith LG
    N J Med; 1986 Jan; Spec No():26-9. PubMed ID: 3513061
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic evaluation of aztreonam in the treatment of infections of the urinary tract in another 800 patients].
    Cortecchia V; Buli P; Brunocilla E; Concetti S; Martelli A
    G Ital Chemioter; 1985; 32(2):449-51. PubMed ID: 3914434
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical study of gentamicin (ampules of 2 ml with measured dose of 80 mg)].
    Linquette M; Benoit G
    Lille Med; 1971 Dec; 16(10):Suppl 5:1482-5. PubMed ID: 5142822
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of aztreonam in the treatment of severe bacterial infections.
    Romero-Vivas J; Rodríguez-Créixems M; Bouza E; Hellín T; Guerrero A; Martínez-Beltrán J; García de la Torre M
    Antimicrob Agents Chemother; 1985 Aug; 28(2):222-6. PubMed ID: 3834832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of aztreonam in the treatment of acute and flare-ups of chronic infectious bronchopneumopathies].
    Aquino G; Barbera S; Romano F; Zottola V
    Clin Ter; 1988 Jan; 124(2):109-16. PubMed ID: 2973921
    [No Abstract]   [Full Text] [Related]  

  • 37. [The use of cephalosporins in hospital practice].
    Petite J
    Schweiz Rundsch Med Prax; 1985 Aug; 74(34):882-4. PubMed ID: 3940160
    [No Abstract]   [Full Text] [Related]  

  • 38. Aztreonam versus cefamandole in the treatment of urinary tract infections.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
    Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the efficiency of Rifadine in general surgery].
    Lagache G; Sonnenfeld H; Dumont JC
    Lille Med; 1975 Apr; 20(4):400-3. PubMed ID: 1152593
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of urinary infections: clinical perspectives.
    Fontana G; Laudi M; Carlone NA; Savoia D
    Chemioterapia; 1987 Feb; 6(1):45-9. PubMed ID: 3549009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.